½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1429568

¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå º¸°í¼­(2024³â)

Next Generation Sequencing Global Market Report 2024

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2028³â¿¡´Â 13.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 197¾ï 5,000¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ¼ºÀåÀº Àα¸ °í·ÉÈ­, ÀÇ·á Á¢±Ù¼º Áõ°¡, ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, COVID-19 »çÅ·ΠÀÎÇÑ Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÀΰøÁö´ÉÀ» È°¿ëÇÑ ºñ¿ë ¹× ½Ã°£ Àý°¨, ´Ù¸¥ ±â¼ú ´ëºñ °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇÑ ºñ¿ë È¿À²ÀûÀÎ ¹æ¹ýÀ¸·Î Èñ±Í Áúȯ ¿¬±¸, ½Å»ý¾Æ ½ºÅ©¸®´×À» À§ÇÑ NGS ±â¼ú Á¦°ø, ½Å»ý¾Æ ½ºÅ©¸®´×À» À§ÇÑ ºòµ¥ÀÌÅÍ ±â¼ú µµÀÔ, ´ë±Ô¸ð °Ô³ð ½ÃÄö½Ì¿¡ ´ëÇÑ ´ë±Ô¸ð °Ô³ð µ¥ÀÌÅÍ ºÐ¼®¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀåÀÇ ¼ºÀåÀº ¾Ï, ¿¡ÀÌÁî, ÁöÁßÇØ ºóÇ÷°ú °°Àº ¸¸¼º ÁúȯÀÇ ¹ß»ý·ü Áõ°¡·Î ÀÎÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. Àα¸ °í·ÉÈ­ ¹× »çȸÀû ÇൿÀÇ º¯È­¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ¸¸¼º ÁúȯÀÇ À¯º´·üÀº Àü ¼¼°èÀûÀ¸·Î Áõ°¡ÇÏ°í ÀÖÀ¸¸ç, ÀÌ´Â ±¤¹üÀ§ÇÏ°í ºñ¿ëÀÌ ¸¹ÀÌ µå´Â Àå±âÀûÀÎ ÀÇ·á ¹®Á¦ÀÇ ½É°¢¼ºÀ» ÃÊ·¡ÇÏ°í ÀÖ½À´Ï´Ù. ¿¬±¸ÀÚµé°ú ÀÓ»óÀǵéÀº ´Ù¾çÇÑ ¾Ï ¿¬±¸¿¡¼­ Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS)À» ´Ù¾çÇÑ Ä¡·á¹ý °áÁ¤¿¡ µµ¿òÀÌ µÇ´Â ¹ÙÀÌ¿À¸¶Ä¿¸¦ ½Äº°Çϱâ À§ÇÑ ´Ù¸ñÀû µµ±¸·Î È°¿ëÇÏ°í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)´Â ¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¸¸¼ºÁúȯ ȯÀÚ Áõ°¡·Î ÀÎÇØ NGS ½ÃÄö½Ì¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀåÀÇ ¸ÅÃâ ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀåÀº °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤¹ÐÀÇ·á¶ó°íµµ ºÒ¸®´Â ¸ÂÃãÀÇ·á´Â °³ÀÎÀÇ À¯ÀüÀû, ȯ°æÀû, »ýÈ°½À°üÀû ¿äÀÎÀ» °í·ÁÇÏ¿© ÀÇ·áÀû °áÁ¤°ú Ä¡·á¸¦ Á¶Á¤ÇÏ´Â Çõ½ÅÀûÀÎ ÀÇ·á Á¢±Ù¹ýÀÔ´Ï´Ù. Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®Àº °³ÀÎÀÇ À¯ÀüÀû ±¸Á¶¸¦ Á¤È®ÇÏ°Ô Æò°¡ÇÏ°í ¸ÂÃãÇü ÀÇ·á Àü·«À» °³¹ßÇÒ ¼ö ÀÖ°ÔÇÔÀ¸·Î½á °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡¼­ ÇÙ½ÉÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù. 2022³â 10¿ù º¸°í¼­´Â 75,000°³ ÀÌ»óÀÇ À¯ÀüÀÚ °Ë»ç Á¦Ç°°ú 300°³ ÀÌ»óÀÇ °³ÀÎ ¸ÂÃãÇü ÀÇ·á Á¦Ç°ÀÌ Á¸ÀçÇϸç, Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀ¸·Î °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖÀ½À» °­Á¶ÇÏ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Ư¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • °íÀÎÇ÷¹À̼ÇÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ¿ìÅ©¶óÀ̳ª¡¤·¯½Ã¾Æ ÀüÀïÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • COVID-19¿¡ ÀÇÇÑ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°èÀÇ ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°èÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû°ú ¼ºÀå, 2018-2023³â
  • ¼¼°èÀÇ ½ÃÀå ±Ô¸ð ¿¹Ãø°ú ¼ºÀå, 2023-2028³â, 2033³â

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2018-2023³â, 2023-2028³â, 2033³â
  • ±â±â
  • ½Ã¾à°ú Å°Æ®
  • ¼ÒÇÁÆ®¿þ¾î
  • ¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå, ±â¼úº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2018-2023³â, 2023-2028³â, 2033³â
  • ÇÕ¼º¿¡ ÀÇÇÑ ¹è¿­ °áÁ¤
  • ÀÌ¿Â ¹ÝµµÃ¼ ½ÃÄö½Ì
  • ´ÜÀÏ ºÐÀÚ ½Ç½Ã°£ ½ÃÄö½Ì
  • ³ª³ëÆ÷¾î ½ÃÄö½Ì
  • ±âŸ ½ÃÄö½Ì ±â¼ú
  • ¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2018-2023³â, 2023-2028³â, 2033³â
  • Áø´Ü
  • Drug Discovery
  • ±âŸ ¿ëµµ

Á¦7Àå Áö¿ª ¹× ±¹°¡ ºÐ¼®

  • ¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå, Áö¿ªº°, ½ÇÀû ¹× ¿¹Ãø, 2018-2023³â, 2023-2028³â, 2033³â
  • ¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå, ±¹°¡º°, ½ÇÀû ¹× ¿¹Ãø, 2018-2023³â, 2023-2028³â, 2033³â

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï »óȲ°ú ±â¾÷ °³¿ä

  • Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå °æÀï »óȲ
  • Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå ±â¾÷ °³¿ä
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • QIAGEN
    • Agilent Technologies, Inc.
    • Pacific Biosciences of California Inc.

Á¦31Àå ±âŸ ÁÖ¿ä ¹× Çõ½ÅÀûÀÎ ±â¾÷

  • Oxford Nanopore Technologies
  • 10x Genomics
  • Bio-Rad Laboratories, Inc.
  • MGI Tech Co., Ltd.
  • Oxford Gene Technology
  • Hoffmann-La Roche Ltd
  • BGI
  • PerkinElmer Inc.
  • Macrogen Inc.
  • Genotypic Technology Pvt. Ltd.
  • Beijing Genomics Institute
  • SciGenom Labs Pvt. Ltd(India)
  • Sysmex
  • Dante Labs
  • Roche

Á¦32Àå °æÀï º¥Ä¡¸¶Å·

Á¦33Àå °æÀï ´ë½Ãº¸µå

Á¦34Àå ÁÖ¿ä ÀμöÇÕº´

Á¦35Àå ÇâÈÄ Àü¸Á°ú °¡´É¼º ºÐ¼®

Á¦36Àå ºÎ·Ï

ksm 24.03.21

Next-generation sequencing is a sequencing technology that provides ultra-high throughput, scalability, and speed, and is utilized to determine the genetic variation associated with diseases or other biological phenomena.

The primary products in the next-generation sequencing market include NextSeq systems, MiniSeq systems, NovaSeq systems, iSeq 100 systems, ion PGM Systems, Ion Proton systems, ion GeneStudio S5 systems, PacBio RS II Systems, Sequel systems, and others. The MiniSeq system combines load-and-go operation with an intuitive user interface for a fast and easy NGS workflow. It integrates clonal amplification, sequencing through synthesis, and base calling into a single benchtop instrument, eliminating the need for additional equipment. Various technologies in next-generation sequencing include sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies applied in diagnostics, drug discovery, and other applications.

The next generation sequencing market research report is one of a series of new reports from The Business Research Company that provides next generation sequencing market statistics, including next generation sequencing industry global market size, regional shares, competitors with a next generation sequencing market share, detailed next generation sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing industry. This next generation sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next generation sequencing market size has grown rapidly in recent years. It will grow from $10.44 billion in 2023 to $11.83 billion in 2024 at a compound annual growth rate (CAGR) of 13.3%. The growth observed in the historical period can be attributed to the rise in funding, increased healthcare expenditure, emerging markets growth, rapid technological advances, and rapid growth in the elderly population.

The next generation sequencing market size is expected to see rapid growth in the next few years. It will grow to $19.75 billion in 2028 at a compound annual growth rate (CAGR) of 13.7%. The anticipated growth in the forecast period can be attributed to the aging population, increased healthcare access, rising prevalence of chronic diseases, and the growing demand for next-generation sequencing due to COVID-19. Major trends in the forecast period include a focus on using artificial intelligence to reduce costs and time, studying rare diseases in a cost-effective manner to maintain a competitive edge over other technologies, offering NGS technologies for newborn screening, and adopting big data technologies to analyze large genomic data.

The growth of the next-generation sequencing market has been fueled by the increasing incidence of chronic conditions such as cancer, AIDS, and thalassemia. The prevalence of chronic illnesses is on the rise globally due to factors such as an aging population and shifts in social behavior, leading to an escalation in widespread and costly long-term medical issues. Researchers and clinicians employ next-generation sequencing (NGS) as a versatile tool in various cancer studies to identify biomarkers that guide treatment decisions. The World Health Organization anticipates a significant increase in the prevalence of chronic diseases. Consequently, the growing number of cases with chronic conditions is expected to drive the demand for NGS sequencing, contributing to the revenue growth of the next-generation sequencing market.

The next-generation sequencing market is set to experience growth driven by the increasing demand for personalized medicine. Personalized medicine, also known as precision medicine, is an innovative healthcare approach that considers an individual's unique genetic, environmental, and lifestyle factors to tailor medical decisions and treatments. Next-generation sequencing plays a foundational role in personalized medicine by enabling the precise assessment of an individual's genetic makeup and the development of customized healthcare strategies. Reports from October 2022 indicate a significant presence of over 75,000 genetic testing products and 300 personalized medicines, highlighting the rising demand for personalized medicine as a key driver for the growth of the next-generation sequencing market.

Major companies in the next-generation sequencing market are focusing on innovation with the introduction of new technologies such as the AVENIO Edge System to enhance profitability. The AVENIO Edge System is a fully automated solution designed for the preparation of samples for next-generation sequencing, encompassing target enrichment, pooling, normalization, and quantification steps. In December 2021, Roche Holding AG, a Switzerland-based pharmaceutical company, launched the AVENIO Edge System. This system streamlines the sequencing process, allowing researchers to concentrate on data processing and interpretation, providing high-quality sequencing results with reduced hands-on time.

Strategic partnerships are a key strategy employed by major companies in the next-generation sequencing market to boost profitability. In October 2022, Illumina Inc., a US-based biotechnology company, formed a partnership with GenoScreen. The collaboration aims to enhance access to genetic testing for multidrug-resistant TB and accelerate global efforts to eradicate the disease. Utilizing NGS technology, the alliance plans to develop and commercialize a novel tuberculosis test for the identification of drug-resistant TB strains.

Major companies operating in the next generation sequencing market report are Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Agilent Technologies, Inc., Pacific Biosciences of California Inc., Oxford Nanopore Technologies, 10x Genomics, Bio-Rad Laboratories, Inc., MGI Tech Co., Ltd., Oxford Gene Technology, Hoffmann-La Roche Ltd., BGI, PerkinElmer Inc., Macrogen Inc., Genotypic Technology Pvt. Ltd., Beijing Genomics Institute, SciGenom Labs Pvt. Ltd (India), Sysmex, Dante Labs, Roche, First Genetics JCS, Helix, Tempus, Massive Bio, Genetricsinc and King Abdullah International Medical Research Center, Inqaba biotec, Pacibo, Microsoft

North America was the largest region in the next generation sequencing market in 2023. Asia-Pacific was the second largest region in the global next generation sequencing market share. The regions covered in the next generation sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the next generation sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The next generation sequencing market consist of sales of genetic sequencing equipment with advanced features and technologies such as ion semiconductor sequencing, nano-pore sequencing, single-molecule real-time sequencing, and other technologies that are used for next generation sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next Generation Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next generation sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next generation sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The next generation sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Instruments; Reagents And Kits; Software
  • 2) By Technology: Sequencing by Synthesis; Ion Semiconductor Sequencing; Single-molecule Real-time Sequencing; Nanopore Sequencing; Other Sequencing Technologies
  • 3) By Application: Diagnostics; Drug Discovery; Other Applications
  • Companies Mentioned: Illumina, Inc.; Thermo Fisher Scientific Inc.; QIAGEN; Agilent Technologies, Inc.; Pacific Biosciences of California Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Next Generation Sequencing Market Characteristics

3. Next Generation Sequencing Market Trends And Strategies

4. Next Generation Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Next Generation Sequencing Market Size and Growth

  • 5.1. Global Next Generation Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Next Generation Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Next Generation Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Next Generation Sequencing Market Segmentation

  • 6.1. Global Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Reagents And Kits
  • Software
  • 6.2. Global Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing
  • Other Sequencing Technologies
  • 6.3. Global Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Drug Discovery
  • Other Applications

7. Next Generation Sequencing Market Regional And Country Analysis

  • 7.1. Global Next Generation Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Next Generation Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Next Generation Sequencing Market

  • 8.1. Asia-Pacific Next Generation Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Next Generation Sequencing Market

  • 9.1. China Next Generation Sequencing Market Overview
  • 9.2. China Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Next Generation Sequencing Market

  • 10.1. India Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Next Generation Sequencing Market

  • 11.1. Japan Next Generation Sequencing Market Overview
  • 11.2. Japan Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Next Generation Sequencing Market

  • 12.1. Australia Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Next Generation Sequencing Market

  • 13.1. Indonesia Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Next Generation Sequencing Market

  • 14.1. South Korea Next Generation Sequencing Market Overview
  • 14.2. South Korea Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Next Generation Sequencing Market

  • 15.1. Western Europe Next Generation Sequencing Market Overview
  • 15.2. Western Europe Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Next Generation Sequencing Market

  • 16.1. UK Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Next Generation Sequencing Market

  • 17.1. Germany Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Next Generation Sequencing Market

  • 18.1. France Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Next Generation Sequencing Market

  • 19.1. Italy Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Next Generation Sequencing Market

  • 20.1. Spain Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Next Generation Sequencing Market

  • 21.1. Eastern Europe Next Generation Sequencing Market Overview
  • 21.2. Eastern Europe Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Next Generation Sequencing Market

  • 22.1. Russia Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Next Generation Sequencing Market

  • 23.1. North America Next Generation Sequencing Market Overview
  • 23.2. North America Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Next Generation Sequencing Market

  • 24.1. USA Next Generation Sequencing Market Overview
  • 24.2. USA Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Next Generation Sequencing Market

  • 25.1. Canada Next Generation Sequencing Market Overview
  • 25.2. Canada Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Next Generation Sequencing Market

  • 26.1. South America Next Generation Sequencing Market Overview
  • 26.2. South America Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Next Generation Sequencing Market

  • 27.1. Brazil Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Next Generation Sequencing Market

  • 28.1. Middle East Next Generation Sequencing Market Overview
  • 28.2. Middle East Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Next Generation Sequencing Market

  • 29.1. Africa Next Generation Sequencing Market Overview
  • 29.2. Africa Next Generation Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Next Generation Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Next Generation Sequencing Market Competitive Landscape
  • 30.2. Next Generation Sequencing Market Company Profiles
    • 30.2.1. Illumina, Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. QIAGEN
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Agilent Technologies, Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Pacific Biosciences of California Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Next Generation Sequencing Market Other Major And Innovative Companies

  • 31.1. Oxford Nanopore Technologies
  • 31.2. 10x Genomics
  • 31.3. Bio-Rad Laboratories, Inc.
  • 31.4. MGI Tech Co., Ltd.
  • 31.5. Oxford Gene Technology
  • 31.6. Hoffmann-La Roche Ltd
  • 31.7. BGI
  • 31.8. PerkinElmer Inc.
  • 31.9. Macrogen Inc.
  • 31.10. Genotypic Technology Pvt. Ltd.
  • 31.11. Beijing Genomics Institute
  • 31.12. SciGenom Labs Pvt. Ltd (India)
  • 31.13. Sysmex
  • 31.14. Dante Labs
  • 31.15. Roche

32. Global Next Generation Sequencing Market Competitive Benchmarking

33. Global Next Generation Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Next Generation Sequencing Market

35. Next Generation Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Next Generation Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Next Generation Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Next Generation Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦